 Talia Quandelacy
Concepts (97)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Influenza, Human | 6 | 2022 | 624 | 1.800 |
Why?
| | Viruses | 2 | 2023 | 165 | 1.270 |
Why?
| | Zika Virus Infection | 5 | 2024 | 172 | 1.140 |
Why?
| | Public Health | 3 | 2026 | 572 | 1.000 |
Why?
| | Dengue | 2 | 2025 | 91 | 0.980 |
Why?
| | Zika Virus | 4 | 2024 | 136 | 0.960 |
Why?
| | Epidemics | 3 | 2021 | 96 | 0.910 |
Why?
| | Coronavirus NL63, Human | 1 | 2023 | 3 | 0.780 |
Why?
| | Coronavirus OC43, Human | 1 | 2023 | 7 | 0.780 |
Why?
| | Coronavirus 229E, Human | 1 | 2023 | 7 | 0.780 |
Why?
| | Respiratory Syncytial Virus, Human | 1 | 2022 | 81 | 0.670 |
Why?
| | Coronavirus Infections | 2 | 2023 | 383 | 0.640 |
Why?
| | Respiratory Tract Infections | 1 | 2023 | 396 | 0.560 |
Why?
| | Seasons | 5 | 2025 | 538 | 0.550 |
Why?
| | Population Surveillance | 3 | 2026 | 484 | 0.490 |
Why?
| | Puerto Rico | 5 | 2022 | 62 | 0.470 |
Why?
| | Influenza Vaccines | 1 | 2020 | 534 | 0.460 |
Why?
| | International Cooperation | 1 | 2011 | 197 | 0.330 |
Why?
| | Models, Statistical | 3 | 2021 | 671 | 0.270 |
Why?
| | Disease Outbreaks | 3 | 2024 | 419 | 0.260 |
Why?
| | Incidence | 4 | 2021 | 2923 | 0.250 |
Why?
| | Americas | 1 | 2025 | 27 | 0.230 |
Why?
| | West Nile Fever | 1 | 2026 | 57 | 0.230 |
Why?
| | Guidelines as Topic | 2 | 2021 | 266 | 0.230 |
Why?
| | Humans | 20 | 2026 | 145475 | 0.200 |
Why?
| | Antibodies, Viral | 3 | 2023 | 674 | 0.190 |
Why?
| | Fever | 2 | 2021 | 319 | 0.180 |
Why?
| | Forecasting | 2 | 2021 | 390 | 0.170 |
Why?
| | Pennsylvania | 1 | 2021 | 138 | 0.170 |
Why?
| | Hemagglutination Inhibition Tests | 1 | 2020 | 38 | 0.160 |
Why?
| | Public Health Surveillance | 1 | 2021 | 83 | 0.160 |
Why?
| | Spatio-Temporal Analysis | 1 | 2020 | 34 | 0.160 |
Why?
| | Tropical Climate | 1 | 2020 | 15 | 0.160 |
Why?
| | Checklist | 1 | 2021 | 110 | 0.160 |
Why?
| | Influenza A Virus, H3N2 Subtype | 1 | 2020 | 50 | 0.160 |
Why?
| | Carrier State | 1 | 2021 | 78 | 0.160 |
Why?
| | Models, Theoretical | 2 | 2020 | 558 | 0.160 |
Why?
| | Disease Transmission, Infectious | 1 | 2020 | 69 | 0.150 |
Why?
| | Antibody Formation | 1 | 2020 | 288 | 0.150 |
Why?
| | Seroepidemiologic Studies | 3 | 2024 | 171 | 0.140 |
Why?
| | Research Design | 2 | 2023 | 1137 | 0.140 |
Why?
| | Pandemics | 3 | 2022 | 1707 | 0.140 |
Why?
| | Temperature | 1 | 2021 | 633 | 0.140 |
Why?
| | Schools | 1 | 2021 | 448 | 0.140 |
Why?
| | Global Health | 2 | 2011 | 403 | 0.130 |
Why?
| | Databases, Factual | 2 | 2021 | 1490 | 0.130 |
Why?
| | Betacoronavirus | 1 | 2020 | 288 | 0.130 |
Why?
| | Child | 4 | 2023 | 22707 | 0.120 |
Why?
| | Computational Biology | 1 | 2021 | 669 | 0.120 |
Why?
| | Colorado | 1 | 2026 | 4554 | 0.120 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 389 | 0.110 |
Why?
| | Biomedical Research | 1 | 2021 | 717 | 0.110 |
Why?
| | Federal Government | 1 | 2011 | 23 | 0.090 |
Why?
| | Government Regulation | 1 | 2011 | 39 | 0.090 |
Why?
| | Utah | 1 | 2011 | 79 | 0.090 |
Why?
| | World Health Organization | 1 | 2011 | 104 | 0.090 |
Why?
| | Sentinel Surveillance | 1 | 2011 | 46 | 0.080 |
Why?
| | Communicable Diseases, Emerging | 1 | 2011 | 39 | 0.080 |
Why?
| | Disaster Planning | 1 | 2011 | 103 | 0.080 |
Why?
| | Malaria | 1 | 2011 | 72 | 0.080 |
Why?
| | Cohort Studies | 1 | 2020 | 6013 | 0.080 |
Why?
| | Program Development | 1 | 2011 | 368 | 0.070 |
Why?
| | Military Medicine | 1 | 2011 | 148 | 0.070 |
Why?
| | Health Policy | 1 | 2011 | 400 | 0.070 |
Why?
| | Pneumonia | 1 | 2013 | 636 | 0.070 |
Why?
| | Sex Factors | 1 | 2013 | 2105 | 0.060 |
Why?
| | Guideline Adherence | 1 | 2011 | 586 | 0.060 |
Why?
| | Age Factors | 1 | 2013 | 3342 | 0.060 |
Why?
| | Adult | 2 | 2023 | 40777 | 0.060 |
Why?
| | Animals | 2 | 2026 | 38030 | 0.050 |
Why?
| | South America | 1 | 2024 | 56 | 0.050 |
Why?
| | Asymptomatic Infections | 1 | 2023 | 37 | 0.050 |
Why?
| | United States | 3 | 2020 | 16098 | 0.050 |
Why?
| | Biological Assay | 1 | 2023 | 130 | 0.050 |
Why?
| | Reproducibility of Results | 2 | 2021 | 3413 | 0.050 |
Why?
| | Infectious Disease Incubation Period | 1 | 2021 | 4 | 0.040 |
Why?
| | Basic Reproduction Number | 1 | 2021 | 6 | 0.040 |
Why?
| | Linear Models | 1 | 2023 | 845 | 0.040 |
Why?
| | Guillain-Barre Syndrome | 1 | 2019 | 23 | 0.040 |
Why?
| | Influenza A virus | 1 | 2020 | 119 | 0.040 |
Why?
| | Communicable Diseases | 1 | 2021 | 166 | 0.040 |
Why?
| | Risk Factors | 1 | 2013 | 10885 | 0.040 |
Why?
| | Adolescent | 2 | 2021 | 22530 | 0.040 |
Why?
| | Young Adult | 1 | 2013 | 14219 | 0.030 |
Why?
| | Decision Support Techniques | 1 | 2021 | 477 | 0.030 |
Why?
| | Male | 3 | 2020 | 72843 | 0.030 |
Why?
| | Female | 3 | 2020 | 78845 | 0.020 |
Why?
| | Prevalence | 1 | 2021 | 2865 | 0.020 |
Why?
| | Aged | 1 | 2013 | 26153 | 0.020 |
Why?
| | Arthropod Vectors | 1 | 2011 | 7 | 0.020 |
Why?
| | Middle Aged | 1 | 2013 | 36215 | 0.020 |
Why?
| | Zoonoses | 1 | 2011 | 38 | 0.020 |
Why?
| | Drug Resistance | 1 | 2011 | 145 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2021 | 6447 | 0.020 |
Why?
| | Infant | 1 | 2021 | 10077 | 0.020 |
Why?
| | Child, Preschool | 1 | 2021 | 11853 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2020 | 17291 | 0.010 |
Why?
|
|
Quandelacy's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|